Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jocelyn Burke

Surgical Critical Care Las Vegas, NV Medical Doctor

NPI 1538393244 CMS profile 3480956

1707 W Charleston Blvd Ste 160, Las Vegas, NV 89102

Open in the dashboard

General payments

$29,533

156 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$86,337 paid to institutions, not to them · program years 2020–2022

Through program year 2025, Jocelyn Burke of Las Vegas, NV is reported in the CMS Open Payments database as having received $29,533 across 156 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $86,337 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $825 10
2024 General $893 12
2023 General $5,999 26
2022 General $9,977 24
2021 General $526 10
2020 General $398 6
2019 General $10,915 68

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jocelyn Burke
  • Surgical Critical Care median
  • Middle half of Surgical Critical Care
  • National median

In program year 2025, general payments to Jocelyn Burke were reported at $825. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.

Show as a table
Year Jocelyn Burke Surgical Critical Care median Middle half National median
2019 $10,915 $161 $57–$631 $163
2020 $398 $116 $33–$383 $114
2021 $526 $121 $37–$475 $132
2022 $9,977 $163 $53–$789 $149
2023 $5,999 $188 $67–$1,031 $160
2024 $893 $216 $80–$1,133 $164
2025 $825 $231 $82–$1,489 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $19,429 67 payments
  2. AbbVie, Inc. $5,127 7 payments
  3. Ethicon US, LLC $1,583 39 payments
  4. Medical Device Business Services, Inc. $928 8 payments
  5. Lucid Diagnostics Inc. $634 6 payments
  6. TELA Bio, Inc. $393 3 payments
  7. Davol Inc. $344 4 payments
  8. Endogastric Solutions, Inc $335 4 payments
  9. Medtronic, Inc. $143 3 payments
  10. Tactile Systems Technology Inc $107 1 payment
  11. Other $511 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $13,695 7 payments
  2. Food and Beverage $6,337 124 payments
  3. Consulting Fee $4,950 1 payment
  4. Travel and Lodging $4,464 23 payments
  5. Entertainment $87 1 payment
Products named General payments · program years 2019–2025
  1. DAVINCI XI $10,000 4 payments
  2. Da Vinci Surgical System $9,429 63 payments
  3. DUOPA $5,095 6 payments
  4. LINX Reflux Management System Endo-Mechanical $1,923 34 payments
  5. EsophyX $335 4 payments
  6. OviTex 2S $309 2 payments
  7. Echelon Flex $306 5 payments
  8. LINX Reflux Management System Endo-Mechanical $166 3 payments
  9. Phasix Mesh BD Interventional Surgery $162 1 payment
  10. Phasix Mesh Surgery $154 2 payments
  11. Other $1,344 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$28,946

Medicare's payments for the services billed

Medicare patients

75

Average age 69

Services billed

202

47 women, 28 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Diabetes 40%
Depression 39%
COPD 36%
Heart failure 35%
Ischemic heart disease 29%
Chronic kidney disease 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
GATTEX
  • Takeda Pharmaceuticals U.S.A., Inc. $22
$22 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

156 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgical Critical Care in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record